Medtronic PLC vs Suncor Energy Inc. — how do they compare? Medtronic PLC trades at $88.48 (market cap $112.24B), while Suncor Energy Inc. trades at $72.23 (market cap $82.76B). The key difference: Medtronic PLC is the larger of the two by market cap, and Medtronic PLC pays the higher dividend (3.28%). Which is the better fit depends on your goals — on Pluang, investors hold Medtronic PLC for 63 Days and Suncor Energy Inc. for 57 Days on average.
| MDT | SU | |
|---|---|---|
Market Cap | $112.24B | $82.76B |
Volume | 105,663,236 | 3,832,959 |
Sector | Health | Energy |
52-Week High | $105.35 | $71.87 |
52-Week Low | $73.75 | $38.17 |
Typical Hold Time | 63 Days | 57 Days |
Enterprise Value | $131.58B | $89.29B |
Dividend Yield | 3.28% | 2.39% |
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $87.75, up 2.62% today, with strong analyst support (60.8% buy ratings) and a $97.80 consensus price target suggesting 11.5% upside. The stock shows consistent earnings beats in recent quarters and maintains a 49-year dividend growth streak. However, technical indicators signal bearish momentum with resistance near $89-90. Revenue growth accelerated to $33.54B in 2025 with net margins improving to 13.93%, though debt levels have risen to 31.1% of assets.
MDT presents a compelling value opportunity with attractive dividend yield and earnings momentum, but faces near-term technical headwinds and increasing leverage. The upcoming Q3 earnings report and MiniMed separation will be critical catalysts. Investors should weigh the strong fundamental recovery against bearish technical signals and monitor debt management closely.
Suncor Energy (SU) trades at $70.91, up 4.07% today and near its 52-week high. The stock shows a bullish technical trend with strong moving average signals, though the RSI indicates potential overbought conditions. Fundamentally, SU exhibits solid profitability with a 14.7% net income margin and attractive valuation ratios, including a P/E of 13.46. Recent news highlights asset sales and leadership transitions, while analyst sentiment remains overwhelmingly positive.
The outlook for SU is favorable, driven by robust cash flow, shareholder returns, and projected earnings growth. Key opportunities include its integrated model and geographic diversification. Risks involve commodity price volatility, operational challenges, and regulatory pressures. With no sell ratings from analysts and strong institutional support, the stock presents a compelling case for growth-oriented investors mindful of sector cyclicality.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →Suncor Energy Inc is an integrated energy company. The company's operations include oil sands development, production and upgrading, offshore oil and gas, petroleum refining in Canada and the U.S. and the company's PetroCanada retail and wholesale distribution networks. The company is developing petroleum resources while advancing the transition to a low-emissions future through investment in power, renewable fuels and hydrogen. It also conducts energy trading activities focused principally on the marketing and trading of crude oil, natural gas, byproducts, refined products and power.
Read more on SU →